Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Comparing once-weekly semaglutide to incretin-based therapies in patients with type 2 diabetes: a systematic review and meta-analysis
Retatrutide is currently undergoing phase 3 clinical trials, which will involve larger, more diverse populations and longer follow-up periods
Its combination of blood sugar control and weight loss makes it a versatile medication for individuals managing diabetes and obesity
2023 Jan;25(1):3-17
Nehra et al
US$ 23.29
US$ 28.84
US$ 21.39
US$ 29.90
US$ 27.91
